Purification and characterization of a lovastatin esterase from Clonostachys compactiuscula

Applied and Environmental Microbiology

Volumn 63, Issue 4, 1997, Pages 1307-1311

  Schimmel, Timothy G ^a   Borneman, W Scott ^a,b   Conder, Michael J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b GENENCOR INTERNATIONAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; ACETIC ACID ETHYL ESTER; ALCOHOL; BUTANOL; ESTERASE; METHANOL; MEVINOLIN; SIMVASTATIN; TETRAHYDROFURAN;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CLONOSTACHYS COMPACTIUSCULA; FUNGUS; HYDROLYSIS; NONHUMAN; PH;

CLONOSTACHYS; CLONOSTACHYS COMPACTIUSCULA; FUNGI;

EID: 0030897549     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.63.4.1307-1311.1997     Document Type: Article

References (32)

1. Alberts, A. W. 1988. Discovery, biochemistry and biology of lovastatin. Am. J. Cardiol. 62:10J-15J.
2. Alberts, A. W. 1990. Effect of HMG CoA rcductase inhibitors on cholesterol synthesis. Drug Invest. 2:9-12.
3. Alberts, A. W., J. Kuron, V. Hunt, J. Huff, J. Hoffman, J. Rothrock, M. Lopez, H. Joshua, E. Harris, A. Patchett, R. Monaghan, S. Currie, E. Stapley, G. Albers-Schonberg, O. Hensens, J. Hirshfield, K. Hoogsteen, J. Liesch, and J. Springer. 1980. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA 77:3957-3961.
4. Askin, D., T. R. Verhoeven, T. M.-H. Liu, and I. Shinkai. 1991. Synthesis of synvinolin: extremely hich conversion alkylation of an ester enolate. J. Org. Chem. 56:4929-4932.
5. Blankenhorn, D. H., S. P. Azen, D. M. Kramsch, W. J. Mack, L. Cashin-Hemphill, H. N. Hodis, L. W. V. DeBoer, P. R. Mahrer, M. J. Masteller, L. I. Vailas, P. Alaupovic, L. J. Hirsch, and the MARS Research Group. 1993. Coronary angiographic changes with lovastatin therapy. Ann. Intern. Med. 119:969-976.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Burnett, W. V., and T. G. Heckler. 1989. Industrial enzymes in drug development, p. 133-154. In J. M. Tabor (ed.), Genetic engineering technology in industrial pharmacy. Marcel Dekker, Inc., New York, N.Y.
8. Casy, A. F., and A. Lipczynski. 1994. 8-Hydroxypenillic acid - NMR characteristics and facile formation from 6-aminopenicillanic acid. J. Pharm. Pharmacol. 46:533-534.
9. Claridge, C. A., A. Gourevitch, and J. Lein. 1960. Formation of 6-aminopenicillanic acid from penicillin by enzymatic hydrolysis. Nature 187:236-238.
10. Cover, W. H., R. L. Dabora. A. Hong, C. Reeves, R. W. Stieber, and V. A. Vinci. October 1993. Mutant strains of Aspergillus terreus for producing 7-[1,2,6,7,8,8A(R)-hexa-hydro-2(S), 6(R)-dimethyl-8(S)-hydroxy-1(S)-naphthyl]-3(R)-dihydroxyheptanoic acid (triol acid). U.S. patent 5250435.
11. Endo, A., M. Kuroda, and Y. Tsujita. 1976. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J. Antibiot. 29:1346-1348.
12. Endo, A. 1979. Monacolin K, a new hypocholesterolemic agent produced by a Monsacus species. J. Antibiot. 32:852-854.
13. Faulds, C. B., and G. Williamson. 1993. Ferulic acid esterase from Aspergillus niger - purification and partial characterization of two forms from a commercial source of pectinase. Biotechnol. Appl. Biochem. 17:349-359.
14. Grigan, N., D. Musel, G. A. Veinberg, and E. Lukevics. 1996. A simple preparative method for tert-butyl protection of aminocephalosporanic acid. Synth. Commun. 26:1183-1185.
15. Gunde-Cimerman, N., A. Plenenitas, and A. Cimerman. 1993. Pleurotus fungi produce mevinolin, an inhibitor of HMG-CoA reductase. FEMS Microbiol. Lett. 113:333-337.
16. Hoffman, W. F., A. W. Alberts, P. S. Anderson, J. S. Chen, R. L. Smith, and A. K. Willard. 1986. 3-Hydroxy-3-methylglularyl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin. J. Med. Chem. 29:849-852.
17. Illanes, A., F. Acevedo, J. C. Gentina, I. Reyes, R. Torres, O. Caragena, A. Ruiz, and M. Vasquez. 1994. Production of penicillin acylase from Bacillus megaterium in complex and defined media. Process Biochem. 29:263-270.
18. Khmelnitsky, Y. L., A. V. Levashov, N. L. Klyachko, and K. Martinek. 1988. Engineering biocatalytic systems in organic media with low water content. Enzyme Microb. Technol. 10:710-715.
19. Kim, M. G., and S. B. Lee. 1996. Penicillin acylase-catalyzed synthesis of pivampicillin - effect of reaction variables and organic cosolvents. J. Mol. Catal. B Enzymatic 1:71-80.
20. Komagata, D., H. Yamashita, and A. Endo. 1986. Microbial conversion of compactin (ML-236B) to ML-236A. J. Antibiot. 39:1574-1577.
21. Krauss, R. M. 1994. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr. Opin. Lipidol. 5:339-349.
22. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
23. Linden, J., M. Samara, S. Decker, E. Johnson, M. Boyer, M. Pecs, W. Adney, and M. Himmel. 1994. Purification and characterization of an acetyl esterase from Aspergillus niger. Appl. Biochem. Biotechnol. 45-46:383-93.
24. Luengo, J. M. 1995. Enzymatic synthesis of hydrophobic penicillins. J. Antibiot. 48:1195-1212.
25. Plosker, G. L., and D. McTavish. 1995. Simvastatin: a reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia. Drugs 50: 334-363.
26. Sleteinger, M., T. Verhoeven, and R. Volante. April 1986. One step process for C-methylation of 2-methylbutyrates. U.S. patent 4,582,915.
27. Stokker, G. E., A. W. Alberts, J. L. Gilfillan, J. W. Huff, and R. L. Smith. 1986. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 5. 6-(Fluoren-9-yl)-and 6-(fluoren-9-ylidenyl)-3,5-dihydroxyhexanoic acids and their lactone derivatives. J. Med. Chem. 29:852-855.
28. Sudhakaran, V. K., B. S. Deshpande, S. S. Ambedkar, and J. G. Shewale. 1992. Molecular aspects of penicillin and cephalosporin acylases. Process Biochem. 27:131-143.
29. Tobert, J. A. 1987. New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase. Circulation 76: 534-538.
30. VanWetswinkel, S., J. Fastrez, and J. Marchandbrynaert. 1994. Synthesis of new sulfonylamido-penicillanic acid sulfones. J. Antibiot. 47:1041-1051.
31. Walker, J. F., and J. A. Tobert. 1988. The clinical efficacy and safety of lovastatin and MK-733 - an overview. Eur. Heart J. 8(Suppl. E):93-96.
32. Waters, D., L. Higginson, P. Gladstone, B. Kimball, M. LeMay, S. J. Boccuzzi, J. Lesperance, and the CCAIT Study Group. 1994. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography - the Canadian coronary atherosclerosis intervention trial. Circulation 89:959-968.